These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27101553)

  • 1. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.
    Zainul Rashid MR; Lim JF; Nawawi NH; Luqman M; Zolkeplai MF; Rangkuty HS; Mohamad Nor NA; Tamil A; Shah SA; Tham SW; Schindler AE
    Gynecol Endocrinol; 2014 Mar; 30(3):217-20. PubMed ID: 24552449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.
    Sammour MB; el-Kabarity H; Fawzy MM; Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):439-40. PubMed ID: 16236493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
    Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
    Tskhay VB; Kovtun NM; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of progestogen supplementation (dydrogesterone) in the prevention of preeclampsia.
    Tskhay V; Schindler A; Shestakova M; Klimova O; Narkevich А
    Gynecol Endocrinol; 2020 Aug; 36(8):698-701. PubMed ID: 31876197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous conception following GnRHa and progestogen therapy in adenomyosis.
    Dasrilsyah RA; Shan LP; Kwang NB; Shafiee MN; Omar MH
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):77-9. PubMed ID: 26812802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone--a unique progestogen.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S1. PubMed ID: 19781875
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
    Patki A; Pawar VC
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():68-72. PubMed ID: 17943542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchorionic hemorrhage treatment with dydrogesterone.
    Pelinescu-Onciul D
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():77-81. PubMed ID: 17943544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
    Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.
    Zaqout M; Aslem E; Abuqamar M; Abughazza O; Panzer J; De Wolf D
    Pediatr Cardiol; 2015 Oct; 36(7):1483-8. PubMed ID: 25972284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
    Stute P
    Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.